230 related articles for article (PubMed ID: 15204149)
41. Minimization of maintenance immunosuppression early after renal transplantation: an interim analysis.
Bemelman FJ; de Maar EF; Press RR; van Kan HJ; ten Berge IJ; Homan van der Heide JJ; de Fijter HW
Transplantation; 2009 Aug; 88(3):421-8. PubMed ID: 19667948
[TBL] [Abstract][Full Text] [Related]
42. Randomized controlled study comparing reduced calcineurin inhibitors exposure versus standard cyclosporine-based immunosuppression.
Hernández D; Miquel R; Porrini E; Fernández A; González-Posada JM; Hortal L; Checa MD; Rodríguez A; García JJ; Rufino M; Torres A
Transplantation; 2007 Sep; 84(6):706-14. PubMed ID: 17893603
[TBL] [Abstract][Full Text] [Related]
43. Plasma of patients with chronic urticaria shows signs of thrombin generation, and its intradermal injection causes wheal-and-flare reactions much more frequently than autologous serum.
Asero R; Tedeschi A; Riboldi P; Cugno M
J Allergy Clin Immunol; 2006 May; 117(5):1113-7. PubMed ID: 16675340
[TBL] [Abstract][Full Text] [Related]
44. Methotrexate: a useful steroid-sparing agent in recalcitrant chronic urticaria.
Perez A; Woods A; Grattan CE
Br J Dermatol; 2010 Jan; 162(1):191-4. PubMed ID: 19903174
[TBL] [Abstract][Full Text] [Related]
45. Urticaria unresponsive to antihistaminic treatment: an open study of therapeutic options based on histopathologic features.
Criado RF; Criado PR; Martins JE; Valente NY; Michalany NS; Vasconcellos C
J Dermatolog Treat; 2008; 19(2):92-6. PubMed ID: 18484427
[TBL] [Abstract][Full Text] [Related]
46. Treatment of severe chronic idiopathic urticaria with oral mycophenolate mofetil in patients not responding to antihistamines and/or corticosteroids.
Shahar E; Bergman R; Guttman-Yassky E; Pollack S
Int J Dermatol; 2006 Oct; 45(10):1224-7. PubMed ID: 17040448
[TBL] [Abstract][Full Text] [Related]
47. [Impact of corticosteroid withdrawal in chronic urticaria: a prospective study of 17 patients].
Augey F; Guillot-Pouget I; Gunera-Saad N; Berard F; Nicolas JF
Ann Dermatol Venereol; 2008 Jan; 135(1):21-5. PubMed ID: 18342069
[TBL] [Abstract][Full Text] [Related]
48. Validation of basophil histamine release against the autologous serum skin test and outcome of serum-induced basophil histamine release studies in a large population of chronic urticaria patients.
Platzer MH; Grattan CE; Poulsen LK; Skov PS
Allergy; 2005 Sep; 60(9):1152-6. PubMed ID: 16076300
[TBL] [Abstract][Full Text] [Related]
49. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
[TBL] [Abstract][Full Text] [Related]
50. Chronic unremitting urticaria: is the use of antihistamines above the licensed dose effective? A preliminary study of cetirizine at licensed and above-licensed doses.
Asero R
Clin Exp Dermatol; 2007 Jan; 32(1):34-8. PubMed ID: 17042777
[TBL] [Abstract][Full Text] [Related]
51. Evaluation of autologous serum skin test results in patients with chronic idiopathic urticaria, allergic/non-allergic asthma or rhinitis and healthy people.
Taskapan O; Kutlu A; Karabudak O
Clin Exp Dermatol; 2008 Nov; 33(6):754-8. PubMed ID: 18954415
[TBL] [Abstract][Full Text] [Related]
52. Topical cyclosporine a in the treatment of superior limbic keratoconjunctivitis: a long-term follow-up.
Sahin A; Bozkurt B; Irkec M
Cornea; 2008 Feb; 27(2):193-5. PubMed ID: 18216575
[TBL] [Abstract][Full Text] [Related]
53. Ebastine in allergic rhinitis and chronic idiopathic urticaria.
Sastre J
Allergy; 2008 Dec; 63 Suppl 89():1-20. PubMed ID: 19032340
[TBL] [Abstract][Full Text] [Related]
54. Six cases of antihistamine-resistant dermographic urticaria treated with oral ciclosporin.
Toda S; Takahagi S; Mihara S; Hide M
Allergol Int; 2011 Dec; 60(4):547-50. PubMed ID: 21778816
[TBL] [Abstract][Full Text] [Related]
55. Phase III safety evaluation of cyclosporine 0.1% ophthalmic emulsion administered twice daily to dry eye disease patients for up to 3 years.
Barber LD; Pflugfelder SC; Tauber J; Foulks GN
Ophthalmology; 2005 Oct; 112(10):1790-4. PubMed ID: 16102833
[TBL] [Abstract][Full Text] [Related]
56. Emedastine difumarate versus loratadine in chronic idiopathic urticaria: a randomized, double-blind, controlled European multicentre clinical trial.
Pons-Guiraud A; Nekam K; Lahovsky J; Costa A; Piacentini A
Eur J Dermatol; 2006; 16(6):649-54. PubMed ID: 17229605
[TBL] [Abstract][Full Text] [Related]
57. Chronic urticaria: do urticaria nonexperts implement treatment guidelines? A survey of adherence to published guidelines by nonexperts.
Ferrer M; Jáuregui I; Bartra J; Dávila I; del Cuvillo A; Montoro J; Mullol J; Valero A; Sastre J
Br J Dermatol; 2009 Apr; 160(4):823-7. PubMed ID: 19120332
[TBL] [Abstract][Full Text] [Related]
58. Treatment of chronic urticaria in children with antihistamines and cyclosporine.
Neverman L; Weinberger M
J Allergy Clin Immunol Pract; 2014; 2(4):434-8. PubMed ID: 25017532
[TBL] [Abstract][Full Text] [Related]
59. Cyclosporine in patients with steroid-resistant nephrotic syndrome: an open-label, nonrandomized, retrospective study.
Ghiggeri GM; Catarsi P; Scolari F; Caridi G; Bertelli R; Carrea A; Sanna-Cherchi S; Emma F; Allegri L; Cancarini G; Rizzoni GF; Perfumo F
Clin Ther; 2004 Sep; 26(9):1411-8. PubMed ID: 15531003
[TBL] [Abstract][Full Text] [Related]
60. The effects of long-term low-dose cyclosporin A treatment on muscles and tendons: an experimental study.
Aktaş RG; Aktaş S; Yazgan O; Altaner S
Ulus Travma Acil Cerrahi Derg; 2009 Jul; 15(4):317-23. PubMed ID: 19669958
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
